Skip to Main Content

Paper Details

Tocilizumab for treatment of mechanically ventilated patients with COVID-19.
medRxiv
47
2020
COVID-19, D, IL-6, Tocilizumab, chimeric antigen receptor, chimeric antigen receptor T cell, chronic pulmonary disease, cytokine release syndrome, patients, respiratory failure, tocilizumab
Author NameAffiliation
Tejal K GandhiUniversity of Michigan ann arbor
Adam S LauringUniversity of Michigan ann arbor
David A HanauerUniversity of Michigan ann arbor
David A HanauerUniversity of Michigan ann arbor
Emily T MartinUniversity of Michigan ann arbor
  • 1 - 5

Datasets

Release 1.2